ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
The Mobile Rundown on MSN

He watched a home purchase nearly collapse and built software to cut deal failures

Terrence Nickelson watched a home purchase nearly fall apart, then taught himself to code and built a real estate platform ...
Investopedia

Understanding the K-Percent Rule: Milton Friedman's Monetary Policy

Clay Halton was a Business Editor at Investopedia and has been working in the finance publishing field for more than five years. He also writes and edits personal finance content, with a focus on ...

Understanding the First Amendment: Key Freedoms and Landmark Cases

Discover how the First Amendment safeguards speech, religion, press, assembly, and petition freedoms in the U.S. Explore its significance and key Supreme Court cases.